Lack of expression for MAGEL2 has also been shown to produce a reduction in orexin-expressing neurons, and thus SNORD116 and MAGEL2 may act in a dose-dependent manner in PWS [(Kozlov et al., 2007; Pace et al., 2020)]. The gene discussed is MAGEL2; the disease is Prader-Willi syndrome.